These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29405898)

  • 1. Efficacy and safety of tigecycline monotherapy versus combination therapy for the treatment of hospital-acquired pneumonia (HAP): a meta-analysis of cohort studies.
    Bai XR; Liu JM; Jiang DC; Yan SY
    J Chemother; 2018 May; 30(3):172-178. PubMed ID: 29405898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia.
    Xu L; Wang YL; Du S; Chen L; Long LH; Wu Y
    Chemotherapy; 2016; 61(6):323-30. PubMed ID: 27144279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline: Alone or in combination?
    Cai Y; Bai N; Liu X; Liang B; Wang J; Wang R
    Infect Dis (Lond); 2016 Jul; 48(7):491-502. PubMed ID: 26982103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
    Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
    Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.
    Ni W; Han Y; Liu J; Wei C; Zhao J; Cui J; Wang R; Liu Y
    Medicine (Baltimore); 2016 Mar; 95(11):e3126. PubMed ID: 26986165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
    Cai Y; Wang R; Liang B; Bai N; Liu Y
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1162-72. PubMed ID: 21173186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis.
    Tasina E; Haidich AB; Kokkali S; Arvanitidou M
    Lancet Infect Dis; 2011 Nov; 11(11):834-44. PubMed ID: 21784708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections: systematic review of literature].
    Moya Cordero P; Ruiz-Aragón J; Molina Linde JM; Márquez-Peláez S; Motiva Sánchez V
    Rev Chilena Infectol; 2013 Dec; 30(6):591-7. PubMed ID: 24522299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
    Kuti JL; Dowzicky M; Nicolau DP
    J Chemother; 2008 Feb; 20(1):69-76. PubMed ID: 18343747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tigecycline in the treatment of infections in light of the new black box warning.
    Dixit D; Madduri RP; Sharma R
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):397-400. PubMed ID: 24597542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
    Sacchidanand S; Penn RL; Embil JM; Campos ME; Curcio D; Ellis-Grosse E; Loh E; Rose G
    Int J Infect Dis; 2005 Sep; 9(5):251-61. PubMed ID: 16099700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tigecycline: a systematic review and meta-analysis.
    Yahav D; Lador A; Paul M; Leibovici L
    J Antimicrob Chemother; 2011 Sep; 66(9):1963-71. PubMed ID: 21685488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis.
    Wang J; Pan Y; Shen J; Xu Y
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):24. PubMed ID: 28381268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
    Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH
    Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs.
    Shen F; Han Q; Xie D; Fang M; Zeng H; Deng Y
    Int J Infect Dis; 2015 Oct; 39():25-33. PubMed ID: 26283551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-defining tigecycline therapy.
    De Rosa FG; Corcione S; Di Perri G; Scaglione F
    New Microbiol; 2015 Apr; 38(2):121-36. PubMed ID: 25915055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C; Ni W; Cai X; Cui J
    Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
    Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The yield of tigecycline in the treatment of community-acquired pneumonia].
    Cilli A
    Tuberk Toraks; 2013; 61(2):155-61. PubMed ID: 23875595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.